诊断和管理II型粘多糖症的诊断和管理
Shao-Jia Mao1, Qing-Qing Chen1, Yang-Li Dai1
1Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Italian journal of pediatrics
|October 8, 2024
概括
粘多糖二型 (MPS II) 是一种罕见的遗传性疾病,由于缺酸-2-硫酶,影响细胞功能. 诊断包括临床症状,成像和遗传检测,在中国治疗选择有限,误诊率高.
科学领域:
- 遗传学 是一个遗传学.
- 生物化学 生化学
- 罕见疾病 罕见疾病
背景情况:
- 粘多糖症II型 (MPS II) 是一种罕见的X相关的衰退性溶酶体储存疾病.
- 在IDS基因中的致病变异导致缺陷的iduronate-2-sulfatase (IDS) 活性.
- 这种缺乏会损害糖氨基 (GAG) 的降解,导致多系统性表现.
研究的目的:
- 总结目前对MPS II的理解.
- 突出诊断方法和挑战.
- 讨论治疗局限性和对中国诊断的影响.
主要方法:
- 对临床表现的审查.
- 诊断工具的描述,包括成像,生化分析和遗传检测.
- 分析当前的治疗策略及其可访问性.
主要成果:
- MPS II呈现出各种症状,如粗的面部特征和骨异常.
- 诊断需要一个综合的方法,结合临床,成像,生化和遗传数据.
- 目前的治疗方法,如酶替代疗法,由于成本和可用性而受到限制.
结论:
- 有效的MPS II诊断依赖于综合的临床和实验室发现.
- 由于治疗和经济限制,症状治疗仍然是主要的.
- 疾病意识和诊断基础设施有限,导致中国的错误诊断率高.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
2
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
2
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Diabetes: Management and Pharmacotherapy
238
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
238
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Varicose Veins II: Diagnostic Studies and Interprofessional Care
4
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
4


